Tyrosine Kinase Inhibitors Available for Chronic Myeloid Leukemia: Efficacy and Safety

Chronic myeloid leukemia (CML) is currently a disease in which patients can enjoy a near normal life-expectancy. However, since the majority of patients will need to remain on treatment indefinitely, physicians in care of CML patients need be familiar with the indications and toxicities of all appro...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Gutiérrez, Valentín, Hernández-Boluda, Juan Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617580/
https://www.ncbi.nlm.nih.gov/pubmed/31334123
http://dx.doi.org/10.3389/fonc.2019.00603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617580/
https://www.ncbi.nlm.nih.gov/pubmed/31334123
http://dx.doi.org/10.3389/fonc.2019.00603

Ejemplares similares